
### [NCIT:C9301](http://purl.obolibrary.org/obo/NCIT_C9301)
**Label:** Central Nervous System Lymphoma

**Subclasses:** [NCIT:C114779](http://purl.obolibrary.org/obo/NCIT_C114779) (Central Nervous System Non-Hodgkin Lymphoma), [NCIT:C114951](http://purl.obolibrary.org/obo/NCIT_C114951) (Central Nervous System Hodgkin Lymphoma), [NCIT:C7611](http://purl.obolibrary.org/obo/NCIT_C7611) (Cerebral Lymphoma), [NCIT:C138019](http://purl.obolibrary.org/obo/NCIT_C138019) (Recurrent Central Nervous System Lymphoma), [NCIT:C5055](http://purl.obolibrary.org/obo/NCIT_C5055) (Cerebral Hodgkin Lymphoma), [NCIT:C95991](http://purl.obolibrary.org/obo/NCIT_C95991) (Dural Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue), [NCIT:C5157](http://purl.obolibrary.org/obo/NCIT_C5157) (Spinal Cord Lymphoma), [NCIT:C5322](http://purl.obolibrary.org/obo/NCIT_C5322) (Central Nervous System Anaplastic Large Cell Lymphoma), [NCIT:C138020](http://purl.obolibrary.org/obo/NCIT_C138020) (Refractory Central Nervous System Lymphoma), [NCIT:C5054](http://purl.obolibrary.org/obo/NCIT_C5054) (Cerebral Lymphoma in Immunocompetent Host), [NCIT:C94756](http://purl.obolibrary.org/obo/NCIT_C94756) (Meningeal Lymphoma), [NCIT:C129602](http://purl.obolibrary.org/obo/NCIT_C129602) (Central Nervous System Intravascular Large B-Cell Lymphoma), [NCIT:C129600](http://purl.obolibrary.org/obo/NCIT_C129600) (Central Nervous System Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma), [NCIT:C129599](http://purl.obolibrary.org/obo/NCIT_C129599) (Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative), [NCIT:C129598](http://purl.obolibrary.org/obo/NCIT_C129598) (Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive), [NCIT:C71720](http://purl.obolibrary.org/obo/NCIT_C71720) (Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System), [NCIT:C7609](http://purl.obolibrary.org/obo/NCIT_C7609) (Cerebral Non-Hodgkin Lymphoma), [NCIT:C5409](http://purl.obolibrary.org/obo/NCIT_C5409) (Central Nervous System T-Cell Non-Hodgkin Lymphoma), 

**Class expressions from DL-Learner:**

- Thing 53.00%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38999](http://purl.obolibrary.org/obo/NCIT_C38999) (BARD1 Pathway))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38998](http://purl.obolibrary.org/obo/NCIT_C38998) (BAD Regulation Pathway))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38997](http://purl.obolibrary.org/obo/NCIT_C38997) (Cancer Susceptibility Pathway))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38996](http://purl.obolibrary.org/obo/NCIT_C38996) (ATM Signaling Pathway))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38995](http://purl.obolibrary.org/obo/NCIT_C38995) (Angiotensin II Signaling Pathway))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38992](http://purl.obolibrary.org/obo/NCIT_C38992) (Ribosomal Biogenesis Pathway))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38981](http://purl.obolibrary.org/obo/NCIT_C38981) (AKT Signaling Pathway))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38975](http://purl.obolibrary.org/obo/NCIT_C38975) (Agrin Pathway))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38971](http://purl.obolibrary.org/obo/NCIT_C38971) (Regulation of Apoptosis Pathway))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3892](http://purl.obolibrary.org/obo/NCIT_C3892) (Mu Heavy Chain Disease))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38850](http://purl.obolibrary.org/obo/NCIT_C38850) (Phosphatidylinositol Signaling System Pathway))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38834](http://purl.obolibrary.org/obo/NCIT_C38834) (MAPK Signaling Pathway))) 38.93%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C38829](http://purl.obolibrary.org/obo/NCIT_C38829) (Focal Adhesion Pathway))) 38.93%


